|
|
![]() |
||||||||||||
|
Dr Richard Hunt |
BACTERIOLOGY | IMMUNOLOGY | MYCOLOGY | PARASITOLOGY | VIROLOGY | ||||||||
|
|||||||||||||
|
LINKS TO OTHER HIV AND AIDS SECTIONS ARE AT THE BOTTOM OF THIS PAGE |
|||||||||||||
|
The genome of HIV is more complex than RSV, however, since it has extra open reading frames that clearly code for small proteins (figure 24a). Antibodies against these small proteins are found in HIV-infected people. Some of these are protein synthesis-controlling proteins. The HIV genome has nine open reading frames (leading to nine primary translation products) but 15 proteins are made in all as a result of cleavage of three of the primary products. The GAG gene and the GAG and POL genes together are
translated into large polyproteins which are then cleaved by a virus-encoded
protease that is part of the POL polyprotein.
In a addition to the nine proteins derived from GAG, POL and ENV, there are six other proteins made by HIV. Three of these are incorporated into the virus (Vif, Vpr and Nef), while the others are not found in the mature virus: Tat and Rev are regulatory proteins and Vpu indirectly assists in assembly. The genes that encode these proteins are known by three letter names that are derived as follows: TAT: Trans-Activator of Transcription REV: Regulator of Virion protein expression NEF: Negative Regulatory Factor VIF: Virion Infectivity Factor VPU: Viral Protein U VPR: Viral Protein R These genes encode small proteins; TAT for example consists of 88 amino acids. They overlap with the structural genes (especially ENV) but are in different reading frames. From the above diagram of the organization of the HIV genome (figure 24), it can be seen that some are encoded in two exons (unlike the structural genes) and therefore their mRNAs can be derived by alternative splicing of structural gene mRNAs. This is rather important to the way in which the levels of these are controlled. Mutants in the TAT and REV genes show that both proteins are necessary for virus production.
|
||||||||||||
|
TAT TAT gene product binds to a sequence in all of the genes of HIV and positively stimulates transcription. It is thus a positive regulator of protein synthesis, including its own synthesis. |
|||||||||||||
|
REV REV binds to an element only in the mRNA for structural proteins (GAG/POL/ENV) and regulates the ratio of GAG/POL/ENV to non-structural, controlling protein (TAT/REV) synthesis. When REV levels are high, structural protein synthesis rises and controlling protein synthesis falls. Thus, REV inhibits its own production and that of TAT. The normal result is homeostasis, low or non-existent virus production and latency in the resting CD4 cell. There is an inherent problem in HIV's lifestyle. It uses genomic RNA as its messenger RNA. This RNA is unspliced and the nucleus has a mechanism to prevent unspliced mRNAs from leaving the nucleus and being translated. It is the function of Rev to overcome this problem.
|
|||||||||||||
|
NEF Nef protein is synthesized early in infection. Despite its small size NEF has several functions. a) Homeostasis leads to problems for the parasitic provirus:
The translation of the NEF gene as a result of the first infecting virus causes the internalization of CD4 antigen from the cell surface and its destruction in lysosomes (figure 25). Thus no more HIV or gp120 can bind to the surface of an infected cell! b) By a different mechanism from its down regulation of CD4 antigen, NEF reduces surface expression of MHC class I molecules. This alters antigen presentation by the infected cell and is proposed to protect the infected cell from attack by cytotoxic T cells c) The name, NEF, comes from negative factor. Originally, it seemed that virions that lacked NEF grew better than wild type. Now the consensus is for the opposite, that is that virus produced in the presence of NEF is a little more infectious than virus produced in its absence. d) It is found that NEF is important for HIV replication in vivo but there seems to be much less effect of NEF in an in vitro cell culture situation. Why this is so has long been obscure. Recently, this question seems to have been solved. The answer is found in the macrophages which are changed in two ways when they are infected with a NEF-expressing HIV (remember that macrophages are the cells that bring HIV into the body and the initial strains of HIV in an infected patient are macrophage-tropic).
|
||||||||||||
|
|
VPU After activation of the T cell, the virus faces another problem: CD4 antigen and Gp120 are being made in the endoplasmic reticulum of the same cell. They are likely to bind to one another before reaching the plasma membrane and such complexes are usually targeted by the cell for degradation. To stop this unfortunate state of affairs, another of the small HIV proteins (VPU) promotes the proteolysis of the CD4 antigen of the host cell as it is made! VPU also enhances viral particle release from the host cell. How it does this is not clear but VPU forms an ion channel in the plasma membrane of the host cell and may alter the ionic composition of the cytoplasm. It also binds to a cellular protein (Vpu-binding protein or UBP) and over-expression of this protein diminishes the enhancing effect of VPU on virus release. UBP may be a negative factor for assembly that must be displaced from one of the GAG proteins before virus can assemble at the cell surface. VPU forms an ion transporting pore in the surface membrane that conducts small ions such as Na and K. The ability of VPU to form channels and its ability to enhance viral release seem to correlate. From its ability to stimulate viral release and also to break down CD4 antigen (which are separate functions of different parts of the VPU molecule), it appears that VPU enhances the pathogenicity of the virus by increasing the number of HIV particles per cell. VIF Vif (viral infectivity factor)
protein, which is essential for infection in vivo, may be very important
in suppressing resistance to HIV infection by the host. Vif is needed during
late stages of virus production and seems to function by suppressing innate
anti-viral activities in T cells and macrophages, the major cells that are infected in humans.
Without Vif, HIV is not infectious in primary human T cells. VPR VPR influences the pathogenesis of HIV and is essential for infection of macrophages, and to a lesser extent of other cells. It also activates HIV LTR-promoted transcription. It causes the arrest of host cell division in the G2 stage of the cell cycle and apoptosis of the infected cell. It acts as a cytoplasmic-nucleus shuttle protein (for the pre-integration complex through the nuclear pores). VPR is found in the serum of HIV-infected patients.
|
||||||||||||
|
WEB RESOURCES |
|||||||||||||
|
|
|||||||||||||
|
OTHER SECTIONS ON HIV PART I HUMAN IMMUNODEFICIENCY VIRUS AND AIDS PART II HIV AND AIDS, THE DISEASE PART III COURSE OF THE DISEASE PART VI SUBTYPES AND CO-RECEPTORS PART VII COMPONENTS AND LIFE CYCLE OF HIV PART XI OTHER CELLS INFECTED BY HIV AND POPULATION POLYMORPHISM |
|||||||||||||
|
|
|||||||||||||